暂无分享,去创建一个
Ning An | Liuqi Jin | Huitong Ding | Jiaoyun Yang | Jing Yuan | Jiaoyun Yang | Huitong Ding | Jing Yuan | Liuqi Jin | Ning An
[1] G. Schellenberg,et al. Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease. , 2006, Archives of neurology.
[2] Asifullah Khan,et al. GECC: Gene Expression Based Ensemble Classification of Colon Samples , 2014, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[3] Geoffrey E. Hinton. Training Products of Experts by Minimizing Contrastive Divergence , 2002, Neural Computation.
[4] M. Prince,et al. World Alzheimer report 2016: improving healthcare for people living with dementia: coverage, quality and costs now and in the future , 2016 .
[5] M. Mattson,et al. Adiponectin protects rat hippocampal neurons against excitotoxicity , 2011, AGE.
[6] Yoshua Bengio,et al. Extracting and composing robust features with denoising autoencoders , 2008, ICML '08.
[7] Rebecca F. Halperin,et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.
[8] M. Kamboh,et al. Molecular Genetics of Late‐Onset Alzheimer's Disease , 2004, Annals of human genetics.
[9] T. Saruta,et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. , 2002, Clinical science.
[10] K. Blennow,et al. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. , 1999, Archives of neurology.
[11] Oskar Hansson,et al. CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease , 2012, PloS one.
[12] O. Forlenza,et al. Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease , 2012, NeuroMolecular Medicine.
[13] G. Schellenberg,et al. Genetic dissection of Alzheimer disease, a heterogeneous disorder. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] H. Soininen,et al. The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease , 1997, Neuroreport.
[15] B. Långström,et al. The use of PET in Alzheimer disease , 2010, Nature Reviews Neurology.
[16] W. Kukull,et al. Epidemiology of dementia: concepts and overview. , 2000, Neurologic clinics.
[17] Ling Li,et al. Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis , 2014, Journal of neurochemistry.
[18] H. Lodish,et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Tanzi,et al. Alzheimer's disease: one disorder, too many genes? , 2004, Human molecular genetics.
[20] S. Henderson. Epidemiology of dementia. , 1998, Annales de medecine interne.
[21] Yoshua Bengio,et al. How transferable are features in deep neural networks? , 2014, NIPS.
[22] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[23] K. Lam,et al. Cross‐talk between adipose tissue and vasculature: role of adiponectin , 2011, Acta physiologica.
[24] C. Mantzoros,et al. Adiponectin in insulin resistance: lessons from translational research. , 2010, The American journal of clinical nutrition.
[25] J. Couzin. Once Shunned, Test for Alzheimer's Risk Headed to Market , 2008, Science.
[26] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[27] Laura Fratiglioni,et al. Worldwide Prevalence and Incidence of Dementia , 1999, Drugs & aging.
[28] B. Dubois,et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. , 1999, American journal of human genetics.
[29] R. Tibshirani,et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins , 2007, Nature Medicine.
[30] Geoffrey E. Hinton. Learning multiple layers of representation , 2007, Trends in Cognitive Sciences.
[31] M. Birnbaum,et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin , 2011, Nature Medicine.
[32] A. Roses. On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease. , 2006, Journal of Alzheimer's disease : JAD.
[33] D. Gustafson. Adiposity and cognitive decline: underlying mechanisms. , 2012, Journal of Alzheimer's disease : JAD.
[34] B. Jeon,et al. Adiponectin protects hippocampal neurons against kainic acid-induced excitotoxicity , 2009, Brain Research Reviews.
[35] P. Deyn,et al. Association study of cholesterol-related genes in Alzheimer’s disease , 2007, Neurogenetics.
[36] B. Cheung,et al. Hypoadiponectinemia as an independent predictor for the progression of carotid atherosclerosis: a 5-year prospective study. , 2014, Metabolic syndrome and related disorders.
[37] Guangzhong Sun,et al. A New Progressive Algorithm for a Multiple Longest Common Subsequences Problem and Its Efficient Parallelization , 2013, IEEE Transactions on Parallel and Distributed Systems.
[38] Juan Manuel Górriz,et al. Association rule-based feature selection method for Alzheimer's disease diagnosis , 2012, Expert Syst. Appl..
[39] Jennifer Williamson,et al. Genetic Aspects of Alzheimer Disease , 2009, The neurologist.
[40] Nancy Reagan,et al. Consensus Report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease" , 1998 .
[41] M. Halil,et al. Adipocytokines and aging: adiponectin and leptin. , 2013, Minerva endocrinologica.
[42] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[43] J. Trojanowski,et al. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification , 2011, Neurobiology of Aging.
[44] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[45] Juhyun Song,et al. Adiponectin Regulates the Polarization and Function of Microglia via PPAR-γ Signaling Under Amyloid β Toxicity , 2017, Front. Cell. Neurosci..
[46] Animesh Nandi,et al. Serum biomarkers for Alzheimer's disease: proteomic discovery. , 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[47] J. Massaro,et al. Exploring the Hierarchical Influence of Cognitive Functions for Alzheimer Disease: The Framingham Heart Study , 2020, Journal of medical Internet research.
[48] Shenghui Zhao,et al. A Comparative Study on Human Activity Recognition Using Inertial Sensors in a Smartphone , 2016, IEEE Sensors Journal.
[49] M. Greicius,et al. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.
[50] K. Blennow,et al. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer’s disease: a community based follow up study , 1998, Journal of neurology, neurosurgery, and psychiatry.